Editorial commentary: Immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care

Clinical Infectious Diseases

Volumn 60, Issue 7, 2015, Pages 1128-1130

  Ford, Nathan ^a,b   Mills, Edward J ^c,d   Egger, Matthias ^b,e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Global Evaluative Sciences   (Canada)

^d UNIVERSITY OF RWANDA   (Rwanda)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

antiretroviral therapy; CD4; ecological bias; immunodeficiency; late presentation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; ECOLOGICAL FALLACY; HEALTH CARE; HEALTH CARE DELIVERY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE STATUS; INCOME; LIFE EXPECTANCY; META ANALYSIS (TOPIC); MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PEER GROUP; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); FEMALE; HIV INFECTIONS; IMMUNOLOGY; MALE;

CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE;

EID: 84926614916     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1138     Document Type: Note

References (26)

1. Meyer-Rath G, Brennan AT, Fox MP, et al. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr 2013; 62:322-8.
2. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286:2568-77.
3. May M, Boulle A, Phiri S, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 2010; 376:449-57.
4. Johnson LF, Mossong J, Dorrington RE, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013; 10:e1001418.
5. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155:209-16.
6. Boulle A, Van CutsemG, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010; 24:563-72.
7. Art-Link Collaboration of International Databases to Evaluate AIDS; Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. TropMed Int Health 2008; 13:870-9.
8. Vitoria M, Vella S, Ford N. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges. Curr Opin HIV AIDS 2013; 8:12-8.
9. Mutimura E, Addison D, Anastos K, et al. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda. AIDS 2015; 29:67-76.
10. Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013. Clin Infect Dis 2015; 60:1120-7.
11. Greenland S, Morgenstern H. Ecological bias, confounding, and effect modification. Int J Epidemiol 1989; 18:269-74.
12. Egger M, Ekouevi DK, Williams C, et al. Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol 2012; 41:1256-64.
13. Lessells RJ, Mutevedzi PC, Iwuji CC, Newell ML. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. J Acquir Immune Defic Syndr 2014; 65:e17-24.
14. Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 2010; 24:2263-70.
15. Geng EH, Hunt PW, Diero LO, et al. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc 2011; 14:46.
16. Mills EJ, Bakanda C, Birungi J, et al. Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc 2011; 14:52.
17. McGuire M, Ben Farhat J, Pedrono G, et al. Task-sharing of HIV care and ART initiation: evaluation of a mixed-care nonphysician provider model for ART delivery in rural Malawi. PLoS One 2013; 8: e74090.
18. Ahonkhai AA, Noubary F, Munro A, et al. Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program. PLoS One 2012; 7:e32993.
19. Lahuerta M, Wu Y, Hoffman S, et al. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-Saharan African countries. Clin Infect Dis 2014; 58:432-41.
20. Somi G, Keogh SC, Todd J, et al. Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health 2012; 17:497-506.
21. IeDEA, ART Cohort Collaborations; Avila D, Althoff KN, Mugglin C, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and highincome countries. J Acquir Immune Defic Syndr 2014; 65:e8-16.
22. Koller M, Patel K, Chi B, et al. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 2015; 68:62-72.
23. Cooper D. Where are we headed with ART-beyond an undetectable viral load. AIDS 2014 Daily Plenary Session. In: 20th International AIDS Conference, Melbourne, 20-25 July 2014.
24. Mocroft A, Lundgren JD, Sabin ML, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med 2013; 10: e1001510.
25. Suthar AB, Ford N, Bachanas PJ, et al. Towards universal voluntary HIV testing and counselling: a systematic review and metaanalysis of community-based approaches. PLoS Med 2013; 10:e1001496.
26. Govindasamy D, Meghij J, Kebede Negussi E, Clare Baggaley R, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low-And middle-income settings-A systematic review. J Int AIDS Soc 2014; 17:19032.